New technologies and modern approaches to drug discovery

Research output: Contribution to journalArticle

Abstract

A variety of advances in molecular biology, genetics, chemistry and robotics have broadened the base for drug discovery and accelerated the pare at which lead compounds are recovered. Molecular biological dissection of human dis cases and application of new human genetic tools to identify loci responsible lor predispositions to various diseases have provided novel targets for potential therapeutic intervention. Advances in antisense technology and development of massively parallel DNA arrays allow rapid validation of potential targets. Combinatorial chemistry, novel assay formats and advances in robotics have expanded the variety of lead compounds that can be recovered against a par licular target and dramatically shortened the time required to find them. The use of combinatorial chemistry and the application of DNA array 'echnologv to toxicology and pharmacology have also facilitated subsequent optimization of leads. These technologies will be discussed, as well as the prospects for fur t her innovations, primarily in the area of miniaturization of the drug discovery process.

Original languageEnglish (US)
JournalFASEB Journal
Volume12
Issue number8
StatePublished - Dec 1 1998

Fingerprint

Drug Discovery
Lead compounds
chemistry
Robotics
Oligonucleotide Array Sequence Analysis
Technology
drugs
Molecular Biology
Miniaturization
Dissection
Molecular biology
DNA
Medical Genetics
toxicology
pharmacology
fur
Toxicology
molecular biology
Assays
Innovation

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

@article{cdb932a81b264a0dbd3e483218df4f7f,
title = "New technologies and modern approaches to drug discovery",
abstract = "A variety of advances in molecular biology, genetics, chemistry and robotics have broadened the base for drug discovery and accelerated the pare at which lead compounds are recovered. Molecular biological dissection of human dis cases and application of new human genetic tools to identify loci responsible lor predispositions to various diseases have provided novel targets for potential therapeutic intervention. Advances in antisense technology and development of massively parallel DNA arrays allow rapid validation of potential targets. Combinatorial chemistry, novel assay formats and advances in robotics have expanded the variety of lead compounds that can be recovered against a par licular target and dramatically shortened the time required to find them. The use of combinatorial chemistry and the application of DNA array 'echnologv to toxicology and pharmacology have also facilitated subsequent optimization of leads. These technologies will be discussed, as well as the prospects for fur t her innovations, primarily in the area of miniaturization of the drug discovery process.",
author = "James Broach",
year = "1998",
month = "12",
day = "1",
language = "English (US)",
volume = "12",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "8",

}

New technologies and modern approaches to drug discovery. / Broach, James.

In: FASEB Journal, Vol. 12, No. 8, 01.12.1998.

Research output: Contribution to journalArticle

TY - JOUR

T1 - New technologies and modern approaches to drug discovery

AU - Broach, James

PY - 1998/12/1

Y1 - 1998/12/1

N2 - A variety of advances in molecular biology, genetics, chemistry and robotics have broadened the base for drug discovery and accelerated the pare at which lead compounds are recovered. Molecular biological dissection of human dis cases and application of new human genetic tools to identify loci responsible lor predispositions to various diseases have provided novel targets for potential therapeutic intervention. Advances in antisense technology and development of massively parallel DNA arrays allow rapid validation of potential targets. Combinatorial chemistry, novel assay formats and advances in robotics have expanded the variety of lead compounds that can be recovered against a par licular target and dramatically shortened the time required to find them. The use of combinatorial chemistry and the application of DNA array 'echnologv to toxicology and pharmacology have also facilitated subsequent optimization of leads. These technologies will be discussed, as well as the prospects for fur t her innovations, primarily in the area of miniaturization of the drug discovery process.

AB - A variety of advances in molecular biology, genetics, chemistry and robotics have broadened the base for drug discovery and accelerated the pare at which lead compounds are recovered. Molecular biological dissection of human dis cases and application of new human genetic tools to identify loci responsible lor predispositions to various diseases have provided novel targets for potential therapeutic intervention. Advances in antisense technology and development of massively parallel DNA arrays allow rapid validation of potential targets. Combinatorial chemistry, novel assay formats and advances in robotics have expanded the variety of lead compounds that can be recovered against a par licular target and dramatically shortened the time required to find them. The use of combinatorial chemistry and the application of DNA array 'echnologv to toxicology and pharmacology have also facilitated subsequent optimization of leads. These technologies will be discussed, as well as the prospects for fur t her innovations, primarily in the area of miniaturization of the drug discovery process.

UR - http://www.scopus.com/inward/record.url?scp=33749107586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749107586&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749107586

VL - 12

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 8

ER -